Keywords: pioglitazone, competition, rezulin/avandia, takeda, japan, glitazone, drug

Pioglitazone; Competition For Rezulin/Avandia?

Article | 26 November 1998

Takeda of Japan's glitazone drug for diabetes mellitus, pioglitazone,looks set to offer strong competition to both Sankyo/Warner-Lambert's Rezulin ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in